Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Robertson

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.
JAMA Oncology|September 30, 2016
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine EraVicki B Benard, Philip E Castle, Steven A Jenison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
Journal of the National Cancer Institute|March 12, 2025
HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytologyRachael Adcock, Cosette M Wheeler, William C Hunt, et al.
Nature Biotechnology|February 21, 2012
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitorsElisabet Wahlberg, Tobias Karlberg, Ekaterina Kouznetsova, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Medicine and Science in Sports and Exercise|November 20, 2002
Performance, biochemical, and endocrine changes during a competitive football gameJay R Hoffman, Carl M Maresh, Robert U Newton, et al.
Journal of the National Cancer Institute|December 10, 2024
Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesCosette M Wheeler, Rachael Adcock, William C Hunt, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.
JAMA Oncology|September 30, 2016
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine EraVicki B Benard, Philip E Castle, Steven A Jenison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
Journal of the National Cancer Institute|March 12, 2025
HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytologyRachael Adcock, Cosette M Wheeler, William C Hunt, et al.
Nature Biotechnology|February 21, 2012
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitorsElisabet Wahlberg, Tobias Karlberg, Ekaterina Kouznetsova, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Medicine and Science in Sports and Exercise|November 20, 2002
Performance, biochemical, and endocrine changes during a competitive football gameJay R Hoffman, Carl M Maresh, Robert U Newton, et al.
Journal of the National Cancer Institute|December 10, 2024
Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesCosette M Wheeler, Rachael Adcock, William C Hunt, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Pageof 11